Results 111 to 120 of about 37,370 (230)

Diagnostic Value of a Combined Serum α-Hydroxybutyrate Dehydrogenase, Carcinoembryonic Antigen and Glycoantigen 125 Test for Early-Stage Breast Cancer

Breast Cancer: Targets and Therapy, 2023
Chuan-Hua Zhan,1 Guo-Jun Liu2 1Department of Clinical Laboratory, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Huangshi, People’s Republic of China; 2Department of Breast Cancer Surgery, Huangshi Central Hospital ...
Zhan CH, Liu GJ
doaj  

Investigating the impact of NHS based ovarian cancer screening [PDF]

, 2010
the UK ovarian cancer is the fifth most common cancer in females and after uterine cancer, the second most common gynaecological cancer. There were 6,596 new cases diagnosed in the UK in 2006.
Nicholson, S. M.
core  

Changes of serum CA125 and PGE2 before and after high-intensity focused ultrasound combined with GnRH-a in treatment of patients with adenomyosis

Open Medicine
This study aimed to investigate the changes of serum carbohydrate antigen 125 (CA125) and prostaglandin E2 (PGE2) in patients with adenomyosis before and after treatment with high-intensity focused ultrasound (HIFU) combined with gonadotropin-releasing ...
Huang Yan, Zhou Yuzhen, Chen Huixian, Xu Yanyi   +3 more
doaj   +1 more source

CA125 Targeted Molecular Imaging of Epithelial Ovarian Cancer

, 2014
Rationale: Ovarian cancer is the most lethal malignancy of the female reproductive system. ~80% of ovarian cancers are epithelial in origin and commonly classified as Epithelial Ovarian Cancer (EOC).
Sharma, Sai Kiran
core   +1 more source

A Case Report of Meigs’ Syndrome Caused by Ovarian Fibrothecoma with High Levels of CA125

International Journal of Women's Health
Liqin Yuan, Lin Cui, Jie Wang, Li Gong Department of Gynecology, Rizhao People’s Hospital, Rizhao, Shandong Province, 276800, People’s Republic of ChinaCorrespondence: Li Gong, Rizhao People’s Hospital, Rizhao, Shandong Province, 276800, People’s ...
Yuan L, Cui L, Wang J, Gong L
doaj  

CA125/Gal-3 categories and risk of adverse events.

, 2015
CA125: carbohydrate antigen 125; Gal-3: galectin-3; HR; hazard ratio; IRR: incident rate ratio.CA125/Gal-3 categories and risk of adverse events.
Vicent Bodí (721787), Juan Sanchis (721790), Eduardo Núñez (721786), Justo Sandino (721781), Gabriel A. Rabinovich (355338), Gema Miñana (721789), Enrique Santas (721784), Julio Núñez (721780), Luis Mainar (721782), Patricia Palau (721783), Maria Pilar Villanueva (721785), Francisco J. Chorro (721788)   +11 more
core   +1 more source

Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer

, 2019
Background The majority of death-related ovarian cancer is epithelial ovarian cancer (EOC). Regarding the Federation of Gynecology and Obstetrics (FIGO) stage IV EOC, the 5-year overall survival (OS) has not changed in last decades.
Ting Wan, Jun-Ya Cao, Jie-Ping Chen, Hua Tu, Qi-Dan Huang, Ji-Hong Liu, Hai-Feng Gu   +6 more
core   +1 more source

Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer

, 2012
The aim of this study was to investigate the role of biomarkers CA125, HE4, and CA72.4 at diagnosis and throughout the follow-up in patients with epithelial ovarian cancer (EOC). Thirty-nine patients with EOC were deemed eligible, and 20 were followed up.
FRATI, Luigi, ANASTASI, Emanuela, Flavia Longo, Barbara Colaprisca, Teresa Granato, MIDULLA, Cecilia   +5 more
core   +1 more source

CA125-Associated Activated Partial Thromboplastin Time and Thrombin Time Decrease in Patients with Adenomyosis [Letter]

Journal of Multidisciplinary Healthcare
Zainarda,1,2,* Hasta Handayani Idrus3,* 1Faculty of Medicine, Hasanuddin University, Makassar, Indoensia; 2Department of Orthopedic, Dody Sarjoto Hospital, Makassar, Indoensia; 3Biomedical Research Center, Research Organization for Health ...
Zainarda, Idrus HH
doaj  

Risk-stratified CA125 screening integrating CA125 trajectories, trajectory-specific progression and transvaginal ultrasound for ovarian cancer

Journal of Ovarian Research
Backgrounds Cancer antigen 125 (CA125) is widely used for screening ovarian cancer (OC), yet its effectiveness remains debated. Potential factors may include ineffective cut-off value for CA125 in screening, as well as a lack of consideration for CA125 ...
Hongyuan Duan, Xiaomin Liu, Yu Zhang, Ya Liu, Yuting Ji, Yunmeng Zhang, Zeyu Fan, Siwen Liu, Lei Yang, Tingting Xu, Jing Tian, Weiqin Li, Zhangyan Lyu, Fangfang Song, Fengju Song, Yubei Huang   +15 more
doaj   +1 more source